Apple, Inc AAPL
S&P 500 ETF Trust SPDR SPY
Alphabet Inc. - Class A Shares GOOGL
Microsoft Corporation MSFT
Meta Platforms Inc META
Netflix, Inc. NFLX
Amazon.com Inc. AMZN
Spotify Technology SA SPOT

BridgeBio Pharma Inc Share Price

BBIO

NSQ

$75.3

-$0.76

(-1%)

Industry: Biotechnology Sector: Health Care

BridgeBio Pharma Inc Analyst Forecast

Overview Returns Financials Ratios News FAQs

BridgeBio Pharma Inc Share Price Chart

BridgeBio Pharma Inc Key Stock Metrics

Market Cap info-icon

This is a company’s total value as determined by the stock market. It is calculated by multiplying the total number of a company's outstanding shares by the current market price of one share.

$14.58B

P/E Ratio

This is the ratio of a security’s current share price to its earnings per share. This ratio determines the relative value of a company’s share.

Volume

This is the total number of shares traded during the most recent trading day.

2.78M

Avg Volume info-icon

This is the average number of shares traded during the most recent 30 days.

Dividend Yield info-icon

This ratio shows how much income you earn in dividend payouts per year for every dollar invested in the stock (or the stock’s annual dividend payment expressed as a percentage of its current price).

0.00%

Beta

This measures the expected move in a stock’s price relative to movements in the overall market. The market, such as the S&P 500 Index, has a beta of 1.0. If a stock has a Beta greater (or lower) than 1.0, it suggests that the stock is more (or less) volatile than the broader market.

1.10

52-week Range info-icon

This shows the range of the stock’s price between the 52-week high (the highest price of the stock for the past 52 weeks) and the 52-week low (the lowest price of the stock for the past 52 weeks).

$28.32 L

$84.94 H

$75.3

About BridgeBio Pharma Inc, Common Stock

BridgeBio Pharma, Inc., a commercial-stage biopharmaceutical company, discovers, creates, tests, and delivers transformative medicines to treat patients who suffer from genetic diseases and cancers. The company offers Attruby, a next-generation oral small molecule near-complete TTR stabilizer for the treatment of cardiomyopathy of wild-type or variant transthyretin-mediated amyloidosis (ATTR-CM); low-dose infigratinib, an oral FGFR1-3 selective tyrosine kinase inhibitor, which is in Phase 3 double-blinded, placebo-controlled pivotal study for the treatment option for children with achondroplasia; low-dose infigratinib, a treatment option for children living with hypochondroplasia, a skeletal dysplasia closely related to achondroplasia which is in Phase 2/3. The company also develops Encaleret, a small molecule antagonist of the calcium sensing receptor, or CaSR, which is in phase 3 clinical trial for treating autosomal dominant hypocalcemia type 1, or ADH1; and BBP-418, a glycosylation substrate pro-drug that is in Phase 3 clinical trial for treating limb-girdle muscular dystrophy type 2I/R9 (LGMD2I/R9). In addition, it engages in developing products for mendelian, oncology, and gene therapy diseases. In addition, it engages in developing products for mendelian, oncology, and gene therapy diseases. The company has license and collaboration agreements with the Alexion Pharma International Operations Unlimited Company, Leland Stanford Junior University and Leidos Biomedical Research, Inc., and Novartis International Pharmaceutical Ltd. BridgeBio Pharma, Inc. was founded in 2015 and is headquartered in Palo Alto, California. more

Industry: BiotechnologySector: Health Care

BridgeBio Pharma Inc Stock Returns

Time Frame	BBIO	Sector	S&P500
1-Week Return	11.77%	-1.08%	-1.38%
1-Month Return	-3.86%	-0.47%	-1.81%
3-Month Return	16.91%	2.13%	1.38%
6-Month Return	50.97%	17.04%	5.68%
1-Year Return	141%	6.56%	11.74%
3-Year Return	556.26%	16.78%	65.15%
5-Year Return	17.05%	34.34%	73.68%
10-Year Return	176.08%	137.88%	260.03%

Time Frame	BBIO	Sector	S&P500
1-Week Return	32,999.14%	-43.23%	-51.55%
1-Month Return	-38.06%	-5.57%	-19.93%
3-Month Return	88.44%	8.92%	5.72%
6-Month Return	130.54%	37.58%	11.85%
1-Year Return	141.00%	6.56%	11.74%
3-Year Return	87.22%	5.31%	18.20%
5-Year Return	3.20%	6.08%	11.67%
10-Year Return	10.69%	9.05%	13.67%

BridgeBio Pharma Inc Financials

	Dec '20	Dec '21	Dec '22	Dec '23	Dec '24	5YR TREND
Total Revenue	8.25M	69.72M	77.65M	9.30M	221.90M	[{"date":"2020-12-31","value":3.72,"profit":true},{"date":"2021-12-31","value":31.42,"profit":true},{"date":"2022-12-31","value":34.99,"profit":true},{"date":"2023-12-31","value":4.19,"profit":true},{"date":"2024-12-31","value":100,"profit":true}]
Cost of Revenue	3.09M	3.11M	3.43M	2.45M	3.88M	[{"date":"2020-12-31","value":79.63,"profit":true},{"date":"2021-12-31","value":80.3,"profit":true},{"date":"2022-12-31","value":88.55,"profit":true},{"date":"2023-12-31","value":63.07,"profit":true},{"date":"2024-12-31","value":100,"profit":true}]
Gross Profit	8.25M	66.60M	74.21M	6.86M	218.02M	[{"date":"2020-12-31","value":3.78,"profit":true},{"date":"2021-12-31","value":30.55,"profit":true},{"date":"2022-12-31","value":34.04,"profit":true},{"date":"2023-12-31","value":3.15,"profit":true},{"date":"2024-12-31","value":100,"profit":true}]
Gross Margin	100.00%	95.53%	95.58%	73.71%	98.25%	[{"date":"2020-12-31","value":100,"profit":true},{"date":"2021-12-31","value":95.53,"profit":true},{"date":"2022-12-31","value":95.58,"profit":true},{"date":"2023-12-31","value":73.71,"profit":true},{"date":"2024-12-31","value":98.25,"profit":true}]

Operating Expenses	482.73M	643.23M	586.42M	614.23M	811.00M	[{"date":"2020-12-31","value":59.52,"profit":true},{"date":"2021-12-31","value":79.31,"profit":true},{"date":"2022-12-31","value":72.31,"profit":true},{"date":"2023-12-31","value":75.74,"profit":true},{"date":"2024-12-31","value":100,"profit":true}]
Operating Income	(474.48M)	(576.63M)	(512.20M)	(607.37M)	(592.97M)	[{"date":"2020-12-31","value":-47448200000,"profit":false},{"date":"2021-12-31","value":-57663200000,"profit":false},{"date":"2022-12-31","value":-51220200000,"profit":false},{"date":"2023-12-31","value":-60737000000,"profit":false},{"date":"2024-12-31","value":-59297300000,"profit":false}]
Total Non-Operating Income/Expense	(63.65M)	(55.47M)	(45.35M)	(109.13M)	(31.26M)	[{"date":"2020-12-31","value":-6364600000,"profit":false},{"date":"2021-12-31","value":-5546700000,"profit":false},{"date":"2022-12-31","value":-4534600000,"profit":false},{"date":"2023-12-31","value":-10913200000,"profit":false},{"date":"2024-12-31","value":-3126200000,"profit":false}]
Pre-Tax Income	(505.49M)	(586.45M)	(484.65M)	(653.25M)	(542.19M)	[{"date":"2020-12-31","value":-50548800000,"profit":false},{"date":"2021-12-31","value":-58645400000,"profit":false},{"date":"2022-12-31","value":-48465200000,"profit":false},{"date":"2023-12-31","value":-65325100000,"profit":false},{"date":"2024-12-31","value":-54219400000,"profit":false}]
Income Taxes	(21.56M)	52.84M	9.31M	71.51M	1.15M	[{"date":"2020-12-31","value":-30.15,"profit":false},{"date":"2021-12-31","value":73.9,"profit":true},{"date":"2022-12-31","value":13.02,"profit":true},{"date":"2023-12-31","value":100,"profit":true},{"date":"2024-12-31","value":1.61,"profit":true}]
Income After Taxes	(483.93M)	(639.30M)	(493.96M)	(724.76M)	(543.35M)	[{"date":"2020-12-31","value":-48392500000,"profit":false},{"date":"2021-12-31","value":-63929700000,"profit":false},{"date":"2022-12-31","value":-49396400000,"profit":false},{"date":"2023-12-31","value":-72476100000,"profit":false},{"date":"2024-12-31","value":-54334700000,"profit":false}]

Income From Continuous Operations	(505.49M)	(586.45M)	(484.65M)	(653.25M)	(543.35M)	[{"date":"2020-12-31","value":-50548800000,"profit":false},{"date":"2021-12-31","value":-58645400000,"profit":false},{"date":"2022-12-31","value":-48465200000,"profit":false},{"date":"2023-12-31","value":-65325100000,"profit":false},{"date":"2024-12-31","value":-54334700000,"profit":false}]
Income From Discontinued Operations	-	-	-	-	-	[{"date":"2020-12-31","value":"-","profit":true},{"date":"2021-12-31","value":"-","profit":true},{"date":"2022-12-31","value":"-","profit":true},{"date":"2023-12-31","value":"-","profit":true},{"date":"2024-12-31","value":"-","profit":true}]
Net Income	(448.72M)	(562.54M)	(481.18M)	(643.20M)	(535.76M)	[{"date":"2020-12-31","value":-44872400000,"profit":false},{"date":"2021-12-31","value":-56253900000,"profit":false},{"date":"2022-12-31","value":-48118300000,"profit":false},{"date":"2023-12-31","value":-64320200000,"profit":false},{"date":"2024-12-31","value":-53576200000,"profit":false}]

EPS (Diluted)	(3.80)	(3.91)	(3.11)	(3.94)	(2.82)	[{"date":"2020-12-31","value":-380,"profit":false},{"date":"2021-12-31","value":-391,"profit":false},{"date":"2022-12-31","value":-311,"profit":false},{"date":"2023-12-31","value":-394,"profit":false},{"date":"2024-12-31","value":-282.4,"profit":false}]

	Dec '20	Dec '21	Dec '22	Dec '23	Dec '24	5YR TREND
Total Revenue	-	745.14%	11.38%	(88.02%)	2285.27%	[{"date":"2020-12-31","value":"-","profit":true},{"date":"2021-12-31","value":32.61,"profit":true},{"date":"2022-12-31","value":0.5,"profit":true},{"date":"2023-12-31","value":-3.85,"profit":false},{"date":"2024-12-31","value":100,"profit":true}]
Cost of Revenue	-	0.84%	10.28%	(28.77%)	58.54%	[{"date":"2020-12-31","value":"-","profit":true},{"date":"2021-12-31","value":1.44,"profit":true},{"date":"2022-12-31","value":17.55,"profit":true},{"date":"2023-12-31","value":-49.14,"profit":false},{"date":"2024-12-31","value":100,"profit":true}]
Gross Profit	-	707.39%	11.43%	(90.76%)	3079.58%	[{"date":"2020-12-31","value":"-","profit":true},{"date":"2021-12-31","value":22.97,"profit":true},{"date":"2022-12-31","value":0.37,"profit":true},{"date":"2023-12-31","value":-2.95,"profit":false},{"date":"2024-12-31","value":100,"profit":true}]
Gross Margin	-	(4.47%)	0.05%	(22.88%)	33.30%	[{"date":"2020-12-31","value":"-","profit":true},{"date":"2021-12-31","value":-13.41,"profit":false},{"date":"2022-12-31","value":0.14,"profit":true},{"date":"2023-12-31","value":-68.71,"profit":false},{"date":"2024-12-31","value":100,"profit":true}]

Operating Expenses	-	33.25%	(8.83%)	4.74%	32.04%	[{"date":"2020-12-31","value":"-","profit":true},{"date":"2021-12-31","value":100,"profit":true},{"date":"2022-12-31","value":-26.57,"profit":false},{"date":"2023-12-31","value":14.26,"profit":true},{"date":"2024-12-31","value":96.35,"profit":true}]
Operating Income	-	21.53%	(11.17%)	18.58%	(2.37%)	[{"date":"2020-12-31","value":"-","profit":true},{"date":"2021-12-31","value":100,"profit":true},{"date":"2022-12-31","value":-51.9,"profit":false},{"date":"2023-12-31","value":86.3,"profit":true},{"date":"2024-12-31","value":-11.01,"profit":false}]
Total Non-Operating Income/Expense	-	(12.85%)	(18.25%)	140.67%	(71.35%)	[{"date":"2020-12-31","value":"-","profit":true},{"date":"2021-12-31","value":-9.14,"profit":false},{"date":"2022-12-31","value":-12.97,"profit":false},{"date":"2023-12-31","value":100,"profit":true},{"date":"2024-12-31","value":-50.73,"profit":false}]
Pre-Tax Income	-	16.02%	(17.36%)	34.79%	(17.00%)	[{"date":"2020-12-31","value":"-","profit":true},{"date":"2021-12-31","value":46.04,"profit":true},{"date":"2022-12-31","value":-49.9,"profit":false},{"date":"2023-12-31","value":100,"profit":true},{"date":"2024-12-31","value":-48.87,"profit":false}]
Income Taxes	-	(345.06%)	(82.38%)	667.93%	(98.39%)	[{"date":"2020-12-31","value":"-","profit":true},{"date":"2021-12-31","value":-51.66,"profit":false},{"date":"2022-12-31","value":-12.33,"profit":false},{"date":"2023-12-31","value":100,"profit":true},{"date":"2024-12-31","value":-14.73,"profit":false}]
Income After Taxes	-	32.11%	(22.73%)	46.72%	(25.03%)	[{"date":"2020-12-31","value":"-","profit":true},{"date":"2021-12-31","value":68.72,"profit":true},{"date":"2022-12-31","value":-48.65,"profit":false},{"date":"2023-12-31","value":100,"profit":true},{"date":"2024-12-31","value":-53.57,"profit":false}]

Income From Continuous Operations	-	16.02%	(17.36%)	34.79%	(16.82%)	[{"date":"2020-12-31","value":"-","profit":true},{"date":"2021-12-31","value":46.04,"profit":true},{"date":"2022-12-31","value":-49.9,"profit":false},{"date":"2023-12-31","value":100,"profit":true},{"date":"2024-12-31","value":-48.36,"profit":false}]
Income From Discontinued Operations	-	-	-	-	-	[{"date":"2020-12-31","value":"-","profit":true},{"date":"2021-12-31","value":"-","profit":true},{"date":"2022-12-31","value":"-","profit":true},{"date":"2023-12-31","value":"-","profit":true},{"date":"2024-12-31","value":"-","profit":true}]
Net Income	-	25.36%	(14.46%)	33.67%	(16.70%)	[{"date":"2020-12-31","value":"-","profit":true},{"date":"2021-12-31","value":75.33,"profit":true},{"date":"2022-12-31","value":-42.95,"profit":false},{"date":"2023-12-31","value":100,"profit":true},{"date":"2024-12-31","value":-49.61,"profit":false}]

EPS (Diluted)	-	2.89%	(20.46%)	26.69%	(28.32%)	[{"date":"2020-12-31","value":"-","profit":true},{"date":"2021-12-31","value":10.85,"profit":true},{"date":"2022-12-31","value":-76.66,"profit":false},{"date":"2023-12-31","value":100,"profit":true},{"date":"2024-12-31","value":-106.13,"profit":false}]

	Sep '24	Dec '24	Mar '25	Jun '25	Sep '25	TREND
Total Revenue	2.73M	5.88M	116.63M	110.56M	120.70M	[{"date":"2024-09-30","value":2.26,"profit":true},{"date":"2024-12-31","value":4.87,"profit":true},{"date":"2025-03-31","value":96.63,"profit":true},{"date":"2025-06-30","value":91.6,"profit":true},{"date":"2025-09-30","value":100,"profit":true}]
Cost of Revenue	598.00K	2.08M	2.64M	3.65M	6.56M	[{"date":"2024-09-30","value":9.11,"profit":true},{"date":"2024-12-31","value":31.75,"profit":true},{"date":"2025-03-31","value":40.21,"profit":true},{"date":"2025-06-30","value":55.66,"profit":true},{"date":"2025-09-30","value":100,"profit":true}]
Gross Profit	2.13M	3.80M	113.99M	106.91M	114.14M	[{"date":"2024-09-30","value":1.87,"profit":true},{"date":"2024-12-31","value":3.33,"profit":true},{"date":"2025-03-31","value":99.87,"profit":true},{"date":"2025-06-30","value":93.67,"profit":true},{"date":"2025-09-30","value":100,"profit":true}]
Gross Margin	78.11%	64.57%	97.74%	96.70%	94.56%	[{"date":"2024-09-30","value":79.92,"profit":true},{"date":"2024-12-31","value":66.06,"profit":true},{"date":"2025-03-31","value":100,"profit":true},{"date":"2025-06-30","value":98.93,"profit":true},{"date":"2025-09-30","value":96.75,"profit":true}]

Operating Expenses	193.88M	229.82M	218.37M	241.19M	259.34M	[{"date":"2024-09-30","value":74.76,"profit":true},{"date":"2024-12-31","value":88.62,"profit":true},{"date":"2025-03-31","value":84.2,"profit":true},{"date":"2025-06-30","value":93,"profit":true},{"date":"2025-09-30","value":100,"profit":true}]
Operating Income	(191.75M)	(226.03M)	(104.37M)	(134.28M)	(145.20M)	[{"date":"2024-09-30","value":-19175000000,"profit":false},{"date":"2024-12-31","value":-22602700000,"profit":false},{"date":"2025-03-31","value":-10437200000,"profit":false},{"date":"2025-06-30","value":-13427800000,"profit":false},{"date":"2025-09-30","value":-14519900000,"profit":false}]
Total Non-Operating Income/Expense	7.73M	(65.35M)	(101.99M)	(81.12M)	(83.19M)	[{"date":"2024-09-30","value":100,"profit":true},{"date":"2024-12-31","value":-845.26,"profit":false},{"date":"2025-03-31","value":-1319.26,"profit":false},{"date":"2025-06-30","value":-1049.27,"profit":false},{"date":"2025-09-30","value":-1076.1,"profit":false}]
Pre-Tax Income	(164.25M)	(266.24M)	(169.61M)	(181.66M)	(186.48M)	[{"date":"2024-09-30","value":-16425400000,"profit":false},{"date":"2024-12-31","value":-26623600000,"profit":false},{"date":"2025-03-31","value":-16960800000,"profit":false},{"date":"2025-06-30","value":-18165800000,"profit":false},{"date":"2025-09-30","value":-18648200000,"profit":false}]
Income Taxes	-	1.15M	2.19M	2.10M	(1.54M)	[{"date":"2024-09-30","value":"-","profit":true},{"date":"2024-12-31","value":52.74,"profit":true},{"date":"2025-03-31","value":100,"profit":true},{"date":"2025-06-30","value":96.07,"profit":true},{"date":"2025-09-30","value":-70.68,"profit":false}]
Income After Taxes	-	(267.39M)	(171.79M)	(183.76M)	(184.94M)	[{"date":"2024-09-30","value":"-","profit":true},{"date":"2024-12-31","value":-26738900000,"profit":false},{"date":"2025-03-31","value":-17179400000,"profit":false},{"date":"2025-06-30","value":-18375800000,"profit":false},{"date":"2025-09-30","value":-18493700000,"profit":false}]

Income From Continuous Operations	(164.25M)	(267.39M)	(169.61M)	(183.76M)	(184.94M)	[{"date":"2024-09-30","value":-16425400000,"profit":false},{"date":"2024-12-31","value":-26738900000,"profit":false},{"date":"2025-03-31","value":-16960800000,"profit":false},{"date":"2025-06-30","value":-18375800000,"profit":false},{"date":"2025-09-30","value":-18493700000,"profit":false}]
Income From Discontinued Operations	-	-	-	-	-	[{"date":"2024-09-30","value":"-","profit":true},{"date":"2024-12-31","value":"-","profit":true},{"date":"2025-03-31","value":"-","profit":true},{"date":"2025-06-30","value":"-","profit":true},{"date":"2025-09-30","value":"-","profit":true}]
Net Income	(162.04M)	(265.05M)	(167.42M)	(181.90M)	(182.74M)	[{"date":"2024-09-30","value":-16204000000,"profit":false},{"date":"2024-12-31","value":-26505000000,"profit":false},{"date":"2025-03-31","value":-16742200000,"profit":false},{"date":"2025-06-30","value":-18190300000,"profit":false},{"date":"2025-09-30","value":-18274300000,"profit":false}]

EPS (Diluted)	(0.86)	(1.37)	(0.99)	(0.95)	(0.95)	[{"date":"2024-09-30","value":-85.96,"profit":false},{"date":"2024-12-31","value":-137.44,"profit":false},{"date":"2025-03-31","value":-98.88,"profit":false},{"date":"2025-06-30","value":-95,"profit":false},{"date":"2025-09-30","value":-95,"profit":false}]

	Sep '24	Dec '24	Mar '25	Jun '25	Sep '25	TREND
Total Revenue	-	115.30%	1882.88%	(5.20%)	9.17%	[{"date":"2024-09-30","value":"-","profit":true},{"date":"2024-12-31","value":6.12,"profit":true},{"date":"2025-03-31","value":100,"profit":true},{"date":"2025-06-30","value":-0.28,"profit":false},{"date":"2025-09-30","value":0.49,"profit":true}]
Cost of Revenue	-	248.49%	26.63%	38.42%	79.66%	[{"date":"2024-09-30","value":"-","profit":true},{"date":"2024-12-31","value":100,"profit":true},{"date":"2025-03-31","value":10.72,"profit":true},{"date":"2025-06-30","value":15.46,"profit":true},{"date":"2025-09-30","value":32.06,"profit":true}]
Gross Profit	-	77.98%	2901.42%	(6.21%)	6.76%	[{"date":"2024-09-30","value":"-","profit":true},{"date":"2024-12-31","value":2.69,"profit":true},{"date":"2025-03-31","value":100,"profit":true},{"date":"2025-06-30","value":-0.21,"profit":false},{"date":"2025-09-30","value":0.23,"profit":true}]
Gross Margin	-	(17.34%)	51.37%	(1.07%)	(2.21%)	[{"date":"2024-09-30","value":"-","profit":true},{"date":"2024-12-31","value":-33.75,"profit":false},{"date":"2025-03-31","value":100,"profit":true},{"date":"2025-06-30","value":-2.07,"profit":false},{"date":"2025-09-30","value":-4.3,"profit":false}]

Operating Expenses	-	18.54%	(4.99%)	10.45%	7.52%	[{"date":"2024-09-30","value":"-","profit":true},{"date":"2024-12-31","value":100,"profit":true},{"date":"2025-03-31","value":-26.9,"profit":false},{"date":"2025-06-30","value":56.38,"profit":true},{"date":"2025-09-30","value":40.59,"profit":true}]
Operating Income	-	17.88%	(53.82%)	28.65%	8.13%	[{"date":"2024-09-30","value":"-","profit":true},{"date":"2024-12-31","value":62.39,"profit":true},{"date":"2025-03-31","value":-187.84,"profit":false},{"date":"2025-06-30","value":100,"profit":true},{"date":"2025-09-30","value":28.38,"profit":true}]
Total Non-Operating Income/Expense	-	(945.26%)	56.08%	(20.47%)	2.56%	[{"date":"2024-09-30","value":"-","profit":true},{"date":"2024-12-31","value":-1685.63,"profit":false},{"date":"2025-03-31","value":100,"profit":true},{"date":"2025-06-30","value":-36.49,"profit":false},{"date":"2025-09-30","value":4.56,"profit":true}]
Pre-Tax Income	-	62.09%	(36.29%)	7.10%	2.66%	[{"date":"2024-09-30","value":"-","profit":true},{"date":"2024-12-31","value":100,"profit":true},{"date":"2025-03-31","value":-58.46,"profit":false},{"date":"2025-06-30","value":11.44,"profit":true},{"date":"2025-09-30","value":4.28,"profit":true}]
Income Taxes	-	-	89.59%	(3.93%)	(173.57%)	[{"date":"2024-09-30","value":"-","profit":true},{"date":"2024-12-31","value":"-","profit":true},{"date":"2025-03-31","value":100,"profit":true},{"date":"2025-06-30","value":-4.39,"profit":false},{"date":"2025-09-30","value":-193.73,"profit":false}]
Income After Taxes	-	-	(35.75%)	6.96%	0.64%	[{"date":"2024-09-30","value":"-","profit":true},{"date":"2024-12-31","value":"-","profit":true},{"date":"2025-03-31","value":-513.36,"profit":false},{"date":"2025-06-30","value":100,"profit":true},{"date":"2025-09-30","value":9.21,"profit":true}]

Income From Continuous Operations	-	62.79%	(36.57%)	8.34%	0.64%	[{"date":"2024-09-30","value":"-","profit":true},{"date":"2024-12-31","value":100,"profit":true},{"date":"2025-03-31","value":-58.24,"profit":false},{"date":"2025-06-30","value":13.29,"profit":true},{"date":"2025-09-30","value":1.02,"profit":true}]
Income From Discontinued Operations	-	-	-	-	-	[{"date":"2024-09-30","value":"-","profit":true},{"date":"2024-12-31","value":"-","profit":true},{"date":"2025-03-31","value":"-","profit":true},{"date":"2025-06-30","value":"-","profit":true},{"date":"2025-09-30","value":"-","profit":true}]
Net Income	-	63.57%	(36.83%)	8.65%	0.46%	[{"date":"2024-09-30","value":"-","profit":true},{"date":"2024-12-31","value":100,"profit":true},{"date":"2025-03-31","value":-57.94,"profit":false},{"date":"2025-06-30","value":13.61,"profit":true},{"date":"2025-09-30","value":0.73,"profit":true}]

EPS (Diluted)	-	59.89%	(28.06%)	(3.92%)	-	[{"date":"2024-09-30","value":"-","profit":true},{"date":"2024-12-31","value":100,"profit":true},{"date":"2025-03-31","value":-46.85,"profit":false},{"date":"2025-06-30","value":-6.55,"profit":false},{"date":"2025-09-30","value":"-","profit":true}]

	Dec '20	Dec '21	Dec '22	Dec '23	Dec '24	5YR TREND
Total Assets
Current Assets	642.82M	888.86M	548.85M	477.59M	720.69M	[{"date":"2020-12-31","value":72.32,"profit":true},{"date":"2021-12-31","value":100,"profit":true},{"date":"2022-12-31","value":61.75,"profit":true},{"date":"2023-12-31","value":53.73,"profit":true},{"date":"2024-12-31","value":81.08,"profit":true}]
Non-current Assets	60.76M	123.93M	74.18M	68.79M	198.65M	[{"date":"2020-12-31","value":30.59,"profit":true},{"date":"2021-12-31","value":62.39,"profit":true},{"date":"2022-12-31","value":37.34,"profit":true},{"date":"2023-12-31","value":34.63,"profit":true},{"date":"2024-12-31","value":100,"profit":true}]
Total Assets	703.59M	1.01B	623.04M	546.38M	919.34M	[{"date":"2020-12-31","value":69.47,"profit":true},{"date":"2021-12-31","value":100,"profit":true},{"date":"2022-12-31","value":61.52,"profit":true},{"date":"2023-12-31","value":53.95,"profit":true},{"date":"2024-12-31","value":90.77,"profit":true}]

Total Liabilities
Current Liabilities	95.65M	135.07M	121.43M	143.84M	154.40M	[{"date":"2020-12-31","value":61.95,"profit":true},{"date":"2021-12-31","value":87.48,"profit":true},{"date":"2022-12-31","value":78.65,"profit":true},{"date":"2023-12-31","value":93.16,"profit":true},{"date":"2024-12-31","value":100,"profit":true}]
Non-current Liabilities	500.05M	1.74B	1.75B	1.75B	2.22B	[{"date":"2020-12-31","value":22.5,"profit":true},{"date":"2021-12-31","value":78.44,"profit":true},{"date":"2022-12-31","value":78.58,"profit":true},{"date":"2023-12-31","value":78.52,"profit":true},{"date":"2024-12-31","value":100,"profit":true}]
Total Liabilities	595.70M	1.88B	1.87B	1.89B	2.38B	[{"date":"2020-12-31","value":25.06,"profit":true},{"date":"2021-12-31","value":79.02,"profit":true},{"date":"2022-12-31","value":78.59,"profit":true},{"date":"2023-12-31","value":79.47,"profit":true},{"date":"2024-12-31","value":100,"profit":true}]

Total Shareholders' equity
Common Stock	125.00K	154.00K	157.00K	181.00K	196.00K	[{"date":"2020-12-31","value":63.78,"profit":true},{"date":"2021-12-31","value":78.57,"profit":true},{"date":"2022-12-31","value":80.1,"profit":true},{"date":"2023-12-31","value":92.35,"profit":true},{"date":"2024-12-31","value":100,"profit":true}]
Retained Earnings	(888.75M)	(1.44B)	(1.92B)	(2.56B)	(3.10B)	[{"date":"2020-12-31","value":-88875500000,"profit":false},{"date":"2021-12-31","value":-143696600000,"profit":false},{"date":"2022-12-31","value":-191814900000,"profit":false},{"date":"2023-12-31","value":-256050100000,"profit":false},{"date":"2024-12-31","value":-309626300000,"profit":false}]
Other Stockholders' Equity	946.34M	566.53M	663.70M	1.21B	1.63B	[{"date":"2020-12-31","value":58.12,"profit":true},{"date":"2021-12-31","value":34.8,"profit":true},{"date":"2022-12-31","value":40.76,"profit":true},{"date":"2023-12-31","value":74.07,"profit":true},{"date":"2024-12-31","value":100,"profit":true}]
Total Shareholders' equity	57.91M	(870.41M)	(1.25B)	(1.35B)	(1.47B)	[{"date":"2020-12-31","value":100,"profit":true},{"date":"2021-12-31","value":-1503.15,"profit":false},{"date":"2022-12-31","value":-2166.64,"profit":false},{"date":"2023-12-31","value":-2338.72,"profit":false},{"date":"2024-12-31","value":-2534.98,"profit":false}]

Total Liabilities & Shareholders Equity	653.61M	1.01B	613.34M	534.66M	909.05M	[{"date":"2020-12-31","value":64.84,"profit":true},{"date":"2021-12-31","value":100,"profit":true},{"date":"2022-12-31","value":60.85,"profit":true},{"date":"2023-12-31","value":53.04,"profit":true},{"date":"2024-12-31","value":90.19,"profit":true}]

	Dec '20	Dec '21	Dec '22	Dec '23	Dec '24	5YR TREND
Total Assets
Current Assets	-	38.27%	(38.25%)	(12.98%)	50.90%	[{"date":"2020-12-31","value":"-","profit":true},{"date":"2021-12-31","value":75.19,"profit":true},{"date":"2022-12-31","value":-75.15,"profit":false},{"date":"2023-12-31","value":-25.51,"profit":false},{"date":"2024-12-31","value":100,"profit":true}]
Non-current Assets	-	103.96%	(40.14%)	(7.27%)	188.78%	[{"date":"2020-12-31","value":"-","profit":true},{"date":"2021-12-31","value":55.07,"profit":true},{"date":"2022-12-31","value":-21.26,"profit":false},{"date":"2023-12-31","value":-3.85,"profit":false},{"date":"2024-12-31","value":100,"profit":true}]
Total Assets	-	43.95%	(38.48%)	(12.30%)	68.26%	[{"date":"2020-12-31","value":"-","profit":true},{"date":"2021-12-31","value":64.38,"profit":true},{"date":"2022-12-31","value":-56.38,"profit":false},{"date":"2023-12-31","value":-18.02,"profit":false},{"date":"2024-12-31","value":100,"profit":true}]

Total Liabilities
Current Liabilities	-	41.21%	(10.10%)	18.46%	7.34%	[{"date":"2020-12-31","value":"-","profit":true},{"date":"2021-12-31","value":100,"profit":true},{"date":"2022-12-31","value":-24.5,"profit":false},{"date":"2023-12-31","value":44.79,"profit":true},{"date":"2024-12-31","value":17.81,"profit":true}]
Non-current Liabilities	-	248.62%	0.19%	(0.08%)	27.36%	[{"date":"2020-12-31","value":"-","profit":true},{"date":"2021-12-31","value":100,"profit":true},{"date":"2022-12-31","value":0.07,"profit":true},{"date":"2023-12-31","value":-0.03,"profit":false},{"date":"2024-12-31","value":11.01,"profit":true}]
Total Liabilities	-	215.32%	(0.55%)	1.12%	25.84%	[{"date":"2020-12-31","value":"-","profit":true},{"date":"2021-12-31","value":100,"profit":true},{"date":"2022-12-31","value":-0.26,"profit":false},{"date":"2023-12-31","value":0.52,"profit":true},{"date":"2024-12-31","value":12,"profit":true}]

Total Shareholders' equity
Common Stock	-	23.20%	1.95%	15.29%	8.29%	[{"date":"2020-12-31","value":"-","profit":true},{"date":"2021-12-31","value":100,"profit":true},{"date":"2022-12-31","value":8.4,"profit":true},{"date":"2023-12-31","value":65.89,"profit":true},{"date":"2024-12-31","value":35.72,"profit":true}]
Retained Earnings	-	61.68%	33.49%	33.49%	20.92%	[{"date":"2020-12-31","value":"-","profit":true},{"date":"2021-12-31","value":100,"profit":true},{"date":"2022-12-31","value":54.29,"profit":true},{"date":"2023-12-31","value":54.29,"profit":true},{"date":"2024-12-31","value":33.92,"profit":true}]
Other Stockholders' Equity	-	(40.13%)	17.15%	81.71%	35.00%	[{"date":"2020-12-31","value":"-","profit":true},{"date":"2021-12-31","value":-49.12,"profit":false},{"date":"2022-12-31","value":20.99,"profit":true},{"date":"2023-12-31","value":100,"profit":true},{"date":"2024-12-31","value":42.83,"profit":true}]
Total Shareholders' equity	-	(1603.15%)	44.14%	7.94%	8.39%	[{"date":"2020-12-31","value":"-","profit":true},{"date":"2021-12-31","value":-3631.94,"profit":false},{"date":"2022-12-31","value":100,"profit":true},{"date":"2023-12-31","value":17.99,"profit":true},{"date":"2024-12-31","value":19.01,"profit":true}]

Total Liabilities & Shareholders Equity	-	54.21%	(39.15%)	(12.83%)	70.02%	[{"date":"2020-12-31","value":"-","profit":true},{"date":"2021-12-31","value":77.42,"profit":true},{"date":"2022-12-31","value":-55.91,"profit":false},{"date":"2023-12-31","value":-18.32,"profit":false},{"date":"2024-12-31","value":100,"profit":true}]

	Sep '24	Dec '24	Mar '25	Jun '25	Sep '25	TREND
Total Assets
Current Assets	444.58M	720.69M	695.17M	912.28M	839.38M	[{"date":"2024-09-30","value":48.73,"profit":true},{"date":"2024-12-31","value":79,"profit":true},{"date":"2025-03-31","value":76.2,"profit":true},{"date":"2025-06-30","value":100,"profit":true},{"date":"2025-09-30","value":92.01,"profit":true}]
Non-current Assets	220.40M	198.65M	186.47M	167.91M	158.87M	[{"date":"2024-09-30","value":100,"profit":true},{"date":"2024-12-31","value":90.13,"profit":true},{"date":"2025-03-31","value":84.6,"profit":true},{"date":"2025-06-30","value":76.19,"profit":true},{"date":"2025-09-30","value":72.08,"profit":true}]
Total Assets	664.98M	919.34M	881.64M	1.08B	998.25M	[{"date":"2024-09-30","value":61.56,"profit":true},{"date":"2024-12-31","value":85.11,"profit":true},{"date":"2025-03-31","value":81.62,"profit":true},{"date":"2025-06-30","value":100,"profit":true},{"date":"2025-09-30","value":92.41,"profit":true}]

Total Liabilities
Current Liabilities	139.22M	154.40M	152.10M	175.85M	216.60M	[{"date":"2024-09-30","value":64.27,"profit":true},{"date":"2024-12-31","value":71.28,"profit":true},{"date":"2025-03-31","value":70.22,"profit":true},{"date":"2025-06-30","value":81.19,"profit":true},{"date":"2025-09-30","value":100,"profit":true}]
Non-current Liabilities	1.74B	2.22B	2.37B	2.68B	2.70B	[{"date":"2024-09-30","value":64.49,"profit":true},{"date":"2024-12-31","value":82.18,"profit":true},{"date":"2025-03-31","value":87.57,"profit":true},{"date":"2025-06-30","value":99.2,"profit":true},{"date":"2025-09-30","value":100,"profit":true}]
Total Liabilities	1.88B	2.38B	2.52B	2.86B	2.92B	[{"date":"2024-09-30","value":64.48,"profit":true},{"date":"2024-12-31","value":81.38,"profit":true},{"date":"2025-03-31","value":86.28,"profit":true},{"date":"2025-06-30","value":97.86,"profit":true},{"date":"2025-09-30","value":100,"profit":true}]

Total Shareholders' equity
Common Stock	195.00K	196.00K	197.00K	198.00K	200.00K	[{"date":"2024-09-30","value":97.5,"profit":true},{"date":"2024-12-31","value":98,"profit":true},{"date":"2025-03-31","value":98.5,"profit":true},{"date":"2025-06-30","value":99,"profit":true},{"date":"2025-09-30","value":100,"profit":true}]
Retained Earnings	(2.83B)	(3.10B)	(3.26B)	(3.45B)	(3.63B)	[{"date":"2024-09-30","value":-283121300000,"profit":false},{"date":"2024-12-31","value":-309626300000,"profit":false},{"date":"2025-03-31","value":-326368500000,"profit":false},{"date":"2025-06-30","value":-344558800000,"profit":false},{"date":"2025-09-30","value":-362833100000,"profit":false}]
Other Stockholders' Equity	1.60B	1.63B	1.62B	1.66B	1.70B	[{"date":"2024-09-30","value":94.46,"profit":true},{"date":"2024-12-31","value":96.05,"profit":true},{"date":"2025-03-31","value":95.28,"profit":true},{"date":"2025-06-30","value":97.79,"profit":true},{"date":"2025-09-30","value":100,"profit":true}]
Total Shareholders' equity	(1.23B)	(1.47B)	(1.65B)	(1.79B)	(1.93B)	[{"date":"2024-09-30","value":-122992200000,"profit":false},{"date":"2024-12-31","value":-146790400000,"profit":false},{"date":"2025-03-31","value":-164839500000,"profit":false},{"date":"2025-06-30","value":-178786000000,"profit":false},{"date":"2025-09-30","value":-193307000000,"profit":false}]

Total Liabilities & Shareholders Equity	653.45M	909.05M	871.91M	1.07B	987.91M	[{"date":"2024-09-30","value":61.03,"profit":true},{"date":"2024-12-31","value":84.9,"profit":true},{"date":"2025-03-31","value":81.43,"profit":true},{"date":"2025-06-30","value":100,"profit":true},{"date":"2025-09-30","value":92.26,"profit":true}]

	Sep '24	Dec '24	Mar '25	Jun '25	Sep '25	TREND
Total Assets
Current Assets	-	62.11%	(3.54%)	31.23%	(7.99%)	[{"date":"2024-09-30","value":"-","profit":true},{"date":"2024-12-31","value":100,"profit":true},{"date":"2025-03-31","value":-5.7,"profit":false},{"date":"2025-06-30","value":50.28,"profit":true},{"date":"2025-09-30","value":-12.87,"profit":false}]
Non-current Assets	-	(9.87%)	(6.13%)	(9.95%)	(5.39%)	[{"date":"2024-09-30","value":"-","profit":true},{"date":"2024-12-31","value":null,"profit":false},{"date":"2025-03-31","value":null,"profit":false},{"date":"2025-06-30","value":null,"profit":false},{"date":"2025-09-30","value":null,"profit":false}]
Total Assets	-	38.25%	(4.10%)	22.52%	(7.59%)	[{"date":"2024-09-30","value":"-","profit":true},{"date":"2024-12-31","value":100,"profit":true},{"date":"2025-03-31","value":-10.72,"profit":false},{"date":"2025-06-30","value":58.88,"profit":true},{"date":"2025-09-30","value":-19.83,"profit":false}]

Total Liabilities
Current Liabilities	-	10.91%	(1.49%)	15.61%	23.17%	[{"date":"2024-09-30","value":"-","profit":true},{"date":"2024-12-31","value":47.07,"profit":true},{"date":"2025-03-31","value":-6.42,"profit":false},{"date":"2025-06-30","value":67.39,"profit":true},{"date":"2025-09-30","value":100,"profit":true}]
Non-current Liabilities	-	27.43%	6.55%	13.28%	0.81%	[{"date":"2024-09-30","value":"-","profit":true},{"date":"2024-12-31","value":100,"profit":true},{"date":"2025-03-31","value":23.89,"profit":true},{"date":"2025-06-30","value":48.43,"profit":true},{"date":"2025-09-30","value":2.94,"profit":true}]
Total Liabilities	-	26.21%	6.03%	13.42%	2.18%	[{"date":"2024-09-30","value":"-","profit":true},{"date":"2024-12-31","value":100,"profit":true},{"date":"2025-03-31","value":23.01,"profit":true},{"date":"2025-06-30","value":51.22,"profit":true},{"date":"2025-09-30","value":8.33,"profit":true}]

Total Shareholders' equity
Common Stock	-	0.51%	0.51%	0.51%	1.01%	[{"date":"2024-09-30","value":"-","profit":true},{"date":"2024-12-31","value":50.77,"profit":true},{"date":"2025-03-31","value":50.51,"profit":true},{"date":"2025-06-30","value":50.25,"profit":true},{"date":"2025-09-30","value":100,"profit":true}]
Retained Earnings	-	9.36%	5.41%	5.57%	5.30%	[{"date":"2024-09-30","value":"-","profit":true},{"date":"2024-12-31","value":100,"profit":true},{"date":"2025-03-31","value":57.76,"profit":true},{"date":"2025-06-30","value":59.54,"profit":true},{"date":"2025-09-30","value":56.65,"profit":true}]
Other Stockholders' Equity	-	1.69%	(0.80%)	2.63%	2.26%	[{"date":"2024-09-30","value":"-","profit":true},{"date":"2024-12-31","value":64.33,"profit":true},{"date":"2025-03-31","value":-30.53,"profit":false},{"date":"2025-06-30","value":100,"profit":true},{"date":"2025-09-30","value":86.17,"profit":true}]
Total Shareholders' equity	-	19.35%	12.30%	8.46%	8.12%	[{"date":"2024-09-30","value":"-","profit":true},{"date":"2024-12-31","value":100,"profit":true},{"date":"2025-03-31","value":63.55,"profit":true},{"date":"2025-06-30","value":43.73,"profit":true},{"date":"2025-09-30","value":41.98,"profit":true}]

Total Liabilities & Shareholders Equity	-	39.12%	(4.09%)	22.81%	(7.74%)	[{"date":"2024-09-30","value":"-","profit":true},{"date":"2024-12-31","value":100,"profit":true},{"date":"2025-03-31","value":-10.44,"profit":false},{"date":"2025-06-30","value":58.3,"profit":true},{"date":"2025-09-30","value":-19.78,"profit":false}]

	Dec '20	Dec '21	Dec '22	Dec '23	Dec '24	5YR TREND
Operating Activities
Net Operating Cash Flow	(399.71M)	(497.93M)	(419.49M)	(527.72M)	(520.73M)	[{"date":"2020-12-31","value":-39971400000,"profit":false},{"date":"2021-12-31","value":-49793400000,"profit":false},{"date":"2022-12-31","value":-41949400000,"profit":false},{"date":"2023-12-31","value":-52772000000,"profit":false},{"date":"2024-12-31","value":-52072600000,"profit":false}]

Investing Activities
Net Investing Cash Flow	(52.99M)	(200.83M)	453.15M	54.03M	60.78M	[{"date":"2020-12-31","value":-11.69,"profit":false},{"date":"2021-12-31","value":-44.32,"profit":false},{"date":"2022-12-31","value":100,"profit":true},{"date":"2023-12-31","value":11.92,"profit":true},{"date":"2024-12-31","value":13.41,"profit":true}]

Financing Activities
Net Financing Cash Flow	447.19M	736.45M	(13.13M)	451.54M	748.46M	[{"date":"2020-12-31","value":59.75,"profit":true},{"date":"2021-12-31","value":98.4,"profit":true},{"date":"2022-12-31","value":-1.75,"profit":false},{"date":"2023-12-31","value":60.33,"profit":true},{"date":"2024-12-31","value":100,"profit":true}]

Net Change in Cash	(5.52M)	37.69M	20.52M	(22.15M)	288.51M	[{"date":"2020-12-31","value":-1.91,"profit":false},{"date":"2021-12-31","value":13.06,"profit":true},{"date":"2022-12-31","value":7.11,"profit":true},{"date":"2023-12-31","value":-7.68,"profit":false},{"date":"2024-12-31","value":100,"profit":true}]

Free Cash Flow
Free Cash Flow	(407.23M)	(546.18M)	(425.81M)	(529.03M)	(521.66M)	[{"date":"2020-12-31","value":-40723200000,"profit":false},{"date":"2021-12-31","value":-54618000000,"profit":false},{"date":"2022-12-31","value":-42581500000,"profit":false},{"date":"2023-12-31","value":-52902600000,"profit":false},{"date":"2024-12-31","value":-52165900000,"profit":false}]

	Dec '20	Dec '21	Dec '22	Dec '23	Dec '24	5YR TREND
Operating Activities
Net Operating Cash Flow	-	24.57%	(15.75%)	25.80%	(1.33%)	[{"date":"2020-12-31","value":"-","profit":true},{"date":"2021-12-31","value":95.25,"profit":true},{"date":"2022-12-31","value":-61.06,"profit":false},{"date":"2023-12-31","value":100,"profit":true},{"date":"2024-12-31","value":-5.14,"profit":false}]

Investing Activities
Net Investing Cash Flow	-	278.97%	(325.64%)	(88.08%)	12.49%	[{"date":"2020-12-31","value":"-","profit":true},{"date":"2021-12-31","value":100,"profit":true},{"date":"2022-12-31","value":-116.73,"profit":false},{"date":"2023-12-31","value":-31.57,"profit":false},{"date":"2024-12-31","value":4.48,"profit":true}]

Financing Activities
Net Financing Cash Flow	-	64.68%	(101.78%)	(3537.91%)	65.76%	[{"date":"2020-12-31","value":"-","profit":true},{"date":"2021-12-31","value":98.37,"profit":true},{"date":"2022-12-31","value":-154.78,"profit":false},{"date":"2023-12-31","value":-5380.17,"profit":false},{"date":"2024-12-31","value":100,"profit":true}]

Net Change in Cash	-	(782.96%)	(45.55%)	(207.96%)	(1402.42%)	[{"date":"2020-12-31","value":"-","profit":true},{"date":"2021-12-31","value":null,"profit":false},{"date":"2022-12-31","value":null,"profit":false},{"date":"2023-12-31","value":null,"profit":false},{"date":"2024-12-31","value":null,"profit":false}]

Free Cash Flow
Free Cash Flow	-	34.12%	(22.04%)	24.24%	(1.39%)	[{"date":"2020-12-31","value":"-","profit":true},{"date":"2021-12-31","value":100,"profit":true},{"date":"2022-12-31","value":-64.59,"profit":false},{"date":"2023-12-31","value":71.04,"profit":true},{"date":"2024-12-31","value":-4.08,"profit":false}]

	Sep '24	Dec '24	Mar '25	Jun '25	Sep '25	TREND
Operating Activities
Net Operating Cash Flow	(180.57M)	(195.33M)	(199.24M)	(80.68M)	(109.57M)	[{"date":"2024-09-30","value":-18056600000,"profit":false},{"date":"2024-12-31","value":-19532600000,"profit":false},{"date":"2025-03-31","value":-19923500000,"profit":false},{"date":"2025-06-30","value":-8068100000,"profit":false},{"date":"2025-09-30","value":-10957400000,"profit":false}]

Investing Activities
Net Investing Cash Flow	38.23M	(3.24M)	(1.59M)	(13.00M)	4.46M	[{"date":"2024-09-30","value":100,"profit":true},{"date":"2024-12-31","value":-8.47,"profit":false},{"date":"2025-03-31","value":-4.17,"profit":false},{"date":"2025-06-30","value":-34.01,"profit":false},{"date":"2025-09-30","value":11.68,"profit":true}]

Financing Activities
Net Financing Cash Flow	707.00K	473.93M	60.33M	302.04M	(894.00K)	[{"date":"2024-09-30","value":0.15,"profit":true},{"date":"2024-12-31","value":100,"profit":true},{"date":"2025-03-31","value":12.73,"profit":true},{"date":"2025-06-30","value":63.73,"profit":true},{"date":"2025-09-30","value":-0.19,"profit":false}]

Net Change in Cash	(141.63M)	275.37M	(140.50M)	208.36M	(106.33M)	[{"date":"2024-09-30","value":-51.43,"profit":false},{"date":"2024-12-31","value":100,"profit":true},{"date":"2025-03-31","value":-51.02,"profit":false},{"date":"2025-06-30","value":75.67,"profit":true},{"date":"2025-09-30","value":-38.61,"profit":false}]

Free Cash Flow
Free Cash Flow	(182.30M)	(198.56M)	(200.83M)	(85.78M)	(110.04M)	[{"date":"2024-09-30","value":-18229800000,"profit":false},{"date":"2024-12-31","value":-19856300000,"profit":false},{"date":"2025-03-31","value":-20083000000,"profit":false},{"date":"2025-06-30","value":-8577500000,"profit":false},{"date":"2025-09-30","value":-11004400000,"profit":false}]

	Sep '24	Dec '24	Mar '25	Jun '25	Sep '25	TREND
Operating Activities
Net Operating Cash Flow	-	8.17%	2.00%	(59.50%)	35.81%	[{"date":"2024-09-30","value":"-","profit":true},{"date":"2024-12-31","value":22.83,"profit":true},{"date":"2025-03-31","value":5.59,"profit":true},{"date":"2025-06-30","value":-166.16,"profit":false},{"date":"2025-09-30","value":100,"profit":true}]

Investing Activities
Net Investing Cash Flow	-	(108.47%)	(50.73%)	715.17%	(134.33%)	[{"date":"2024-09-30","value":"-","profit":true},{"date":"2024-12-31","value":-15.17,"profit":false},{"date":"2025-03-31","value":-7.09,"profit":false},{"date":"2025-06-30","value":100,"profit":true},{"date":"2025-09-30","value":-18.78,"profit":false}]

Financing Activities
Net Financing Cash Flow	-	66934.09%	(87.27%)	400.66%	(100.30%)	[{"date":"2024-09-30","value":"-","profit":true},{"date":"2024-12-31","value":100,"profit":true},{"date":"2025-03-31","value":-0.13,"profit":false},{"date":"2025-06-30","value":0.6,"profit":true},{"date":"2025-09-30","value":-0.15,"profit":false}]

Net Change in Cash	-	(294.42%)	(151.02%)	(248.30%)	(151.03%)	[{"date":"2024-09-30","value":"-","profit":true},{"date":"2024-12-31","value":null,"profit":false},{"date":"2025-03-31","value":null,"profit":false},{"date":"2025-06-30","value":null,"profit":false},{"date":"2025-09-30","value":null,"profit":false}]

Free Cash Flow
Free Cash Flow	-	8.92%	1.14%	(57.29%)	28.29%	[{"date":"2024-09-30","value":"-","profit":true},{"date":"2024-12-31","value":31.53,"profit":true},{"date":"2025-03-31","value":4.04,"profit":true},{"date":"2025-06-30","value":-202.48,"profit":false},{"date":"2025-09-30","value":100,"profit":true}]

BridgeBio Pharma Inc Ratios

BridgeBio Pharma Inc Liquidity Ratios

These ratios help you determine the liquidity of the company. Higher is better.

	BBIO
Cash Ratio	2.98
Current Ratio	3.88
Quick Ratio	3.76

BridgeBio Pharma Inc Asset Efficiency Ratios

These ratios help you understand the company's efficiency in using its assets to generate returns. Higher is better. For ROE, average long term is around 14%, less than 10% is poor.

	BBIO
ROA (LTM)	-43.48%
ROE (LTM)	-1789.67%

BridgeBio Pharma Inc Liability Ratios

These ratios help you understand the company's liabilities, gauging the riskiness of the investment.

	BBIO
Debt Ratio Lower is generally better. Negative is bad.	2.93
Common Equity/Total Assets Higher is better. Lower can suggest investment is riskier.	-1.94

BridgeBio Pharma Inc Valuation Ratios

These ratios help you understand the company's valuation. Lower may indicate cheaper stocks.

	BBIO
Trailing PE	NM
Forward PE	NM
P/S (TTM)	39.72
P/B	123.68
Price/FCF	NM
EV/R	42.69
EV/Ebitda	NM

Discover more

Tesla, Inc.

Apple, Inc.

Alphabet Inc. - Class A Shares

Meta Platforms Inc

Amazon.com Inc.

Microsoft Corporation

NVIDIA Corporation

Berkshire Hathaway Inc. Hld B

Eli Lilly and Company

FAQs

What is BridgeBio Pharma Inc share price today?

BridgeBio Pharma Inc (BBIO) share price today is $75.3

Can Indians buy BridgeBio Pharma Inc shares?

Yes, Indians can buy shares of BridgeBio Pharma Inc (BBIO) on Vested. To buy

from India, you can open a US Brokerage account on Vested today by clicking on Sign Up or Invest in BBIO stock at the top of this page. The account opening process is completely digital and secure, and takes a few minutes to complete.

Can Fractional shares of BridgeBio Pharma Inc be purchased?

Yes, you can purchase fractional shares of BridgeBio Pharma Inc (BBIO) via the Vested app. You can start investing in BridgeBio Pharma Inc (BBIO) with a minimum investment of $1.

How to invest in BridgeBio Pharma Inc shares from India?

You can invest in shares of BridgeBio Pharma Inc (BBIO) via Vested in three simple steps:

Click on Sign Up or Invest in BBIO stock at the top of this page
Breeze through our fully digital and secure KYC process and open your US Brokerage account in a few minutes
Transfer USD funds to your US Brokerage account and start investing in BridgeBio Pharma Inc shares

What is BridgeBio Pharma Inc 52-week high and low stock price?

The 52-week high price of BridgeBio Pharma Inc (BBIO) is $84.94. The 52-week low price of BridgeBio Pharma Inc (BBIO) is $28.32.

What is BridgeBio Pharma Inc price-to-earnings (P/E) ratio?

The price-to-earnings (P/E) ratio of BridgeBio Pharma Inc (BBIO) is

What is BridgeBio Pharma Inc price-to-book (P/B) ratio?

The price-to-book (P/B) ratio of BridgeBio Pharma Inc (BBIO) is 123.68

What is BridgeBio Pharma Inc dividend yield?

The dividend yield of BridgeBio Pharma Inc (BBIO) is 0.00%

What is the Market Cap of BridgeBio Pharma Inc?

The market capitalization of BridgeBio Pharma Inc (BBIO) is $14.58B

What is BridgeBio Pharma Inc's stock symbol?

The stock symbol (or ticker) of BridgeBio Pharma Inc is BBIO

How Can Investors Use BridgeBio Pharma Inc Share Price Data for Long-Term Investment Decisions?

Consider the share price of BridgeBio Pharma Inc as a long-term story and not a daily point list. The price represents a movement of the stock in both good and bad times when looked at over many years. This assists the investors to know whether BridgeBio Pharma Inc has succeeded to expand steadily and overcome market declines. With this price movement observed and the way the business is progressing, it is easier to make a decision whether the stock is worth having in the long term or not.

How does USD - INR currency movement impact returns from BridgeBio Pharma Inc shares for Indian investors?

When investing in BridgeBio Pharma Inc shares, you are not based in India then your investment is not just based on the stock price. It is also determined by the currency movement of the dollar in relation to the rupee. When you have an appreciation of the BridgeBio Pharma Inc stock and the dollar appreciation is also the same, you gain more in terms of rupees. When the rupee appreciated, it will lower your profits. This currency flow is a silent cause of great contribution to your ultimate returns over many years.

How should investors compare BridgeBio Pharma Inc share price with other stocks in the same sector?

Rather than merely checking the share price of BridgeBio Pharma Inc and comparing it with that of other stocks in the same sector, one can check how robust the business is. Investors tend to compare such aspects as profits, cash generation, and the stability of the revenues of the company. This means that BridgeBio Pharma Inc stock in most cases does not react in the same manner as other companies in the sector due to its brand and services revenue.

Feedback

Request to add more info/data

Inform about wrong info/data

Link copied

Signup to access all features and start your US investing journey!

Open your account in minutes
Take your portfolio global, starting at just $1

Get started

Add ticker to compare

Apple, Inc AAPL
Alphabet Inc. - Class A Shares GOOGL
Microsoft Corporation MSFT
Meta Platforms Inc META
Netflix, Inc. NFLX
Amazon.com Inc. AMZN
Spotify Technology SA SPOT

US Stocks & ETFs

Private Markets

Managed Portfolios (Previously Vests)

Global Funds

Global

Explore our India Diversification

INR Bonds

Alt FDs

BridgeBio Pharma Inc Share Price

BridgeBio Pharma Inc Analyst Forecast

BridgeBio Pharma Inc Share Price Chart

BridgeBio Pharma Inc Key Stock Metrics

About BridgeBio Pharma Inc, Common Stock

BridgeBio Pharma Inc Stock Returns

BridgeBio Pharma Inc Financials

BridgeBio Pharma Inc Ratios

BridgeBio Pharma Inc Liquidity Ratios

BridgeBio Pharma Inc Asset Efficiency Ratios

BridgeBio Pharma Inc Liability Ratios

BridgeBio Pharma Inc Valuation Ratios

Discover more

FAQs

Feedback

Signup to access all features and start your US investing journey!

Add ticker to compare

Company

Explore Products

Popular US Stocks ¹

Popular US ETFs ²

Curated Portfolios (Vests)

Risk Disclosure - US Markets

US Stocks & ETFs

Private Markets

Managed Portfolios (Previously Vests)

Global Funds

Global

Explore our India Diversification

INR Bonds

Alt FDs

BridgeBio Pharma Inc Share Price

BridgeBio Pharma Inc Analyst Forecast

BridgeBio Pharma Inc Share Price Chart

BridgeBio Pharma Inc Key Stock Metrics

About BridgeBio Pharma Inc, Common Stock

BridgeBio Pharma Inc Stock Returns

BridgeBio Pharma Inc Financials

BridgeBio Pharma Inc Ratios

BridgeBio Pharma Inc Liquidity Ratios

BridgeBio Pharma Inc Asset Efficiency Ratios

BridgeBio Pharma Inc Liability Ratios

BridgeBio Pharma Inc Valuation Ratios

Discover more

FAQs

Feedback

Signup to access all features and start your US investing journey!

Add ticker to compare

Popular US Stocks 1

Popular US ETFs 2

Curated Portfolios (Vests)

Popular US Stocks ¹

Popular US ETFs ²